Ozempic (semaglutide) is an injectable medication initially designed to manage type 2 diabetes. Over the past few years, its potential to aid weight loss has captured more public attention. When ...

So now that I've lost fat, I'm in better shape, and I am healthier. I'm actually able to feel better, look better, and I'm more energised. I can get up earlier, I don't feel as tired as like midday or ...

"Soon, I could walk farther without needing my asthma inhaler, and exercise began to feel easier and more enjoyable." ...

Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications quickly and directly to customers’ homes, today announced expanded access to the new Zepbound® KwikPen® ...

Market opportunities lie in the expansion of medical weight loss programs, rising demand for GLP-1 drugs, and increased roles for physicians and bariatricians in weight management. With declining ...

Amazon Pharmacy has expanded access to the new Zepbound KwikPen, a multi-dose injectable treatment for weight management ...

Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...

Amazon (NASDAQ:AMZN) said it would begin offering the Zepbound KwikPen, a multi-dose tirzepatide device developed by Eli Lilly (NYSE:LLY), through its platform. The medication will offer transparent ...

Novo Nordisk's reports to the FDA spiked shortly after an inspection found the Ozempic producer ignored reports of deaths and potential side effects.

March 3 (Reuters) - The U.S. Food and Drug Administration has issued warning letters to 30 telehealth companies for making false or misleading claims about compounded versions of popular GLP-1 ...

Since December alone, four Australian fashion labels have been forced to defend their use of models so skinny their rib cages, hips or shoulder blades were protruding, following formal complaints to ...